{"schema_version":"1","generated_at":"2026-10-29T14:34:34.295Z","data_as_of":null,"url":"https://www.findmykol.com/kol/bobby-liaw","json_url":"https://www.findmykol.com/kol/bobby-liaw/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"bobby-liaw","name":"Bobby Liaw","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Tisch Cancer Institute","institution_url":"https://www.findmykol.com/institution/tisch-cancer-institute","city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1851528731","orcid":"0000-0003-4371-0267","openalex":"A5059178256"},"summary":"Bobby Liaw is an Oncology physician affiliated with Tisch Cancer Institute. OpenAlex indexes 68 publications with 524 citations (h-index 9); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":68,"cited_by_count":524,"h_index":9,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT02903160","title":"Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"Icahn School of Medicine at Mount Sinai","source_url":"https://clinicaltrials.gov/study/NCT02903160","trial_url":"https://www.findmykol.com/trial/NCT02903160"}],"source":"trials"},"payments":{"company_count":17,"program_years":{"first":2021,"last":null},"rows_total":29,"shown":3,"withheld":26,"rows":[{"payer":"Janssen Biotech, Inc.","program_year":2025,"amount_usd":14653.35,"payment_count":21,"source_url":"https://openpaymentsdata.cms.gov/search?query=1851528731"},{"payer":"EMD Serono, Inc.","program_year":2025,"amount_usd":2760,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1851528731"},{"payer":"SpringWorks Therapeutics, Inc.","program_year":2025,"amount_usd":2100,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1851528731"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1851528731","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"CXCL9:SPP1 ratio: Macrophage polarization and outcomes with pembrolizumab or enfortumab vedotin plus pembrolizumab in metastatic urothelial cancer.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.4573","status":"verified"},{"title":"A Pilot Study of the Combination of 5-Azacitidine and All-trans Retinoic Acid in Biochemically Recurrent Prostate Cancer","year":2025,"journal":"medRxiv","source_url":"https://doi.org/10.1101/2025.08.11.25333316","status":"verified"},{"title":"Phase 1 clinical trial of AMG 340, a prostate-specific membrane antigen (PSMA)-targeted T-cell engager with a novel low-affinity CD3 binding domain designed to mitigate toxicity for the treatment of metastatic castration-resistant prostate cancer (mCRPC).","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.e14587","status":"verified"},{"title":"Prostate Cancer and Obesity: Current Hypotheses and Challenges","year":2024,"journal":"International Journal of Cancer Care and Delivery","source_url":"https://doi.org/10.53876/001c.120988","status":"verified"},{"title":"Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor–targeted Therapy","year":2024,"journal":"American Journal of Clinical Oncology","source_url":"https://doi.org/10.1097/coc.0000000000001087","status":"verified"}],"source":"works"},"contact":{"address_1":"325 W 15TH ST","city":"New York","state":"NY","zip":"100115903","phone":"212-604-6010","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1851528731","source":"identity"},"similar":[{"name":"Matthew Galsky","slug":"matthew-galsky","institution":"Tisch Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/matthew-galsky","json_url":"https://www.findmykol.com/kol/matthew-galsky/profile.json"},{"name":"Santiago Thibaud","slug":"santiago-thibaud","institution":"Tisch Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/santiago-thibaud","json_url":"https://www.findmykol.com/kol/santiago-thibaud/profile.json"},{"name":"James Ferrara","slug":"james-ferrara","institution":"Tisch Cancer Institute","specialty":"Pediatric Hematology-Oncology","url":"https://www.findmykol.com/kol/james-ferrara","json_url":"https://www.findmykol.com/kol/james-ferrara/profile.json"},{"name":"Deniz Demircioğlu","slug":"deniz-demircioglu","institution":"Tisch Cancer Institute","url":"https://www.findmykol.com/kol/deniz-demircioglu","json_url":"https://www.findmykol.com/kol/deniz-demircioglu/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":26,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2015-10-12","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}